In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA)
Journal of Antimicrobial Chemotherapy · 05.05.2026 · 81 (6)
DOI: 10.1093/jac/dkag182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 01.06.2026. Verfasst von David Lasry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Drug Resistance, Bacterial. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de Recherche du Québec, Department of Medicine, McGill University.
Abstract (Originalsprache)
Background
Pseudomonas aeruginosa readily evolves antimicrobial resistance through regulatory plasticity and stress-adaptive pathways. Clinically, antibiotics lacking intrinsic antipseudomonal activity are often favoured with the assumption that they avoid selective pressure on P. aeruginosa. Whether subinhibitory exposure to such ‘non-antipseudomonal antibiotics’ (NAPA) can nevertheless select for canonical resistance pathways remains incompletely defined.
Methods
Three P. aeruginosa strains (ATCC 27853 and two bloodstream isolates) were serially passaged over 14 days in the presence of ertapenem, ceftriaxone or moxifloxacin at one-third the baseline MIC. MICs for antipseudomonal antibiotics (meropenem, ceftazidime, ciprofloxacin) were measured at serial time points and after a 3-day antibiotic-free recovery (Day 14). Whole-genome sequencing was performed longitudinally to identify mutations.
Results
NAPA exposure led to reproducible elevations in antipseudomonal MICs: ertapenem triggered up to a 29-fold increase in meropenem MIC, ceftriaxone up to a 31-fold rise in ceftazidime MIC and moxifloxacin up to a 12-fold increase in ciprofloxacin MIC. Elevated MICs persisted on Day 14 despite absence of further antibiotic pressure. Genomic analysis revealed convergent evolution of mutations in efflux regulator genes (nfxB, nalC, nalD, amrR) and the β-lactamase–regulating gene dacB, emerging during periods of MIC escalation and mapping to regulatory pathways governing efflux and AmpC expression.
Conclusions
Subinhibitory exposure to antibiotics without intrinsic antipseudomonal activity reproducibly selected for heritable multidrug-resistant phenotypes in P. aeruginosa. Convergent mutations arose in regulatory genes classically associated with direct antipseudomonal antibiotic pressure, demonstrating that resistance architectures can be selected independent of target engagement and underscoring the potential for collateral resistance under antibiotic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Québec, Canada.
- Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre, Montréal, Québec, Canada.
- Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
- Department of Critical Care Medicine, McGill University Health Centre, Montréal, Québec, Canada.
ORCID-Profile: David Lasry, Cedric P Yansouni, Todd C Lee, Alexander Lawandi
Förderung
- Fonds de Recherche du Québec
- Department of Medicine
- McGill University
Zitieren
APA
Lasry, D., Harrison, L. B., Bamba, R., Corsini, R., Yansouni, C. P., Cheng, M. P., Lee, T. C., & Lawandi, A. (2026). In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA). Journal of Antimicrobial Chemotherapy, 81(6). https://doi.org/10.1093/jac/dkag182
Vancouver
Lasry D, Harrison LB, Bamba R, Corsini R, Yansouni CP, Cheng MP, et al. In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA). Journal of Antimicrobial Chemotherapy. 2026;81(6). doi:10.1093/jac/dkag182
BibTeX
@article{Lasry2026,
author = {Lasry, David and Harrison, Luke B and Bamba, Reggie and Corsini, Rachel and Yansouni, Cedric P and Cheng, Matthew P and Lee, Todd C and Lawandi, Alexander},
title = {In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA)},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/jac/dkag182}
}
EUVIMED